These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22003984)

  • 1. Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA.
    Bryson DI; Zhang W; McLendon PM; Reineke TM; Santos WL
    ACS Chem Biol; 2012 Jan; 7(1):210-7. PubMed ID: 22003984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition of HIV-1 RNAs with branched peptides.
    Peralta AN; Dai Y; Sherpa C; Le Grice SFJ; Santos WL
    Methods Enzymol; 2019; 623():373-400. PubMed ID: 31239054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of a branched peptide library with HIV-1 TAR RNA.
    Bryson DI; Zhang W; Ray WK; Santos WL
    Mol Biosyst; 2009 Sep; 5(9):1070-3. PubMed ID: 19668873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 drug discovery: targeting folded RNA structures with branched peptides.
    Wynn JE; Santos WL
    Org Biomol Chem; 2015 Jun; 13(21):5848-58. PubMed ID: 25958855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
    J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays.
    Sztuba-Solinska J; Shenoy SR; Gareiss P; Krumpe LR; Le Grice SF; O'Keefe BR; Schneekloth JS
    J Am Chem Soc; 2014 Jun; 136(23):8402-10. PubMed ID: 24820959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
    Chavali SS; Bonn-Breach R; Wedekind JE
    J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5' end of the HIV-2 leader RNA.
    Pachulska-Wieczorek K; Purzycka KJ; Adamiak RW
    Nucleic Acids Res; 2006; 34(10):2984-97. PubMed ID: 16738137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thienopyridine carboxamides as selective binders of HIV-1 trans Activation Response (TAR) and Rev Response Element (RRE) RNAs.
    Li XD; Liu L; Cheng L
    Org Biomol Chem; 2018 Dec; 16(47):9191-9196. PubMed ID: 30465585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combined RNA-protein interaction analysis distinguishes HIV-1 Gag protein binding sites from structural change in the viral RNA leader.
    Kenyon JC; Prestwood LJ; Lever AM
    Sci Rep; 2015 Oct; 5():14369. PubMed ID: 26449409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.
    Warui DM; Baranger AM
    J Med Chem; 2012 May; 55(9):4132-41. PubMed ID: 22480197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Click dimers to target HIV TAR RNA conformation.
    Kumar S; Kellish P; Robinson WE; Wang D; Appella DH; Arya DP
    Biochemistry; 2012 Mar; 51(11):2331-47. PubMed ID: 22339203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
    Filikov AV; Mohan V; Vickers TA; Griffey RH; Cook PD; Abagyan RA; James TL
    J Comput Aided Mol Des; 2000 Aug; 14(6):593-610. PubMed ID: 10921774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.
    Morgner N; Barth HD; Brutschy B; Scheffer U; Breitung S; Göbel M
    J Am Soc Mass Spectrom; 2008 Nov; 19(11):1600-11. PubMed ID: 18693035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.